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PIH7
BODY COMPOSITION CHANGES IN THE PREOPERATIVE PERIOD AND 
AFTER SURGERY
Hock M, Domány B, Garai J, Kránicz J, Kriszbacher I, Boncz I, Bódis J
University of Pécs, Pécs, Hungary
OBJECTIVES: Our aim was to examine the changes of body composition in the 
perioperative period. METHODS: The authors examine the body composition of 11 
postmenopausal women (Total Body Water (TBW), Extracellular Water (EW), Intra-
cellular Water (IW), Fat Mass (FM), Fat Free Mass (FFM)) 1month and 1 day before 
as well as 1day and 1 month after the operation. The performed operations were 
anterior colporrhaphy with or without posterior colporrhaphy or enterocele repair. 
Preoperative medical preparation ordered the use of oral (1 mg estriol/die; T. Ovestin) 
and local (U. Ovestin; 1 mg/g estriol) estrogen for a month. Fluid replacement was 
adequate as ordered for patients with ﬁ rst-degree severity (average operative load, 
prohibition of ﬂ uid intake is not longer than 6–12 hours, maximum blood loss is 
250–500 ml) during the operation and in the postoperative period. Body composition 
parameters were measured by MF HUMAN—IM SCAN Master 1.0. The statistical 
data were calculated according to mean, standard deviation, median, range, Fisher’s 
exact test, Student’s t-test methods and the results were considered to be signiﬁ cant 
at P < 0,05. RESULTS: The mean age of the subjects was 59.4 years (8.58 SD, median 
57 years, range 48–72 years), the average number of preceding pregnancies was 3.33 
(1.68 SD) with 2,46 deliveries (1.46 SD). In the preoperative period (between the 1st 
and the 2nd measurements) a signiﬁ cant decrease (p = 0,056) was found in EW. In 
comparison of the 2nd and the 3rd measurements a signiﬁ cant decrease (ECW p = 0,027; 
TBW p = 0,04; FM p = 0,019; FFM p = 0,019) was observed except for the parameters 
of ICW (p = 0,15). Between the 1st and 30th day after the surgery changes in ﬁ ndings 
were not signiﬁ cant (ECW p = 0,81; TBW p = 0,83; FM p = 0,5; FFM p = 0,3; ICW 
p = 0,616). CONCLUSIONS: The results suggest that body composition changes in 
the perioperative period should be followed.
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CHANGES IN PELVIC FLOOR MUSCLE FUNCTION DURING THE 
PERIOPERATIVE PERIOD OF COLPORRHAPHY
Hock M, Domány B, Rácz S, Garai J, Kránicz J, Kriszbacher I, Boncz I, Bódis J
University of Pécs, Pécs, Hungary
OBJECTIVES: Our goal was to follow up the changes of pelvic muscle function during 
the perioperative period. METHODS: Fifteen women in postmenopausal period were 
included in the study. The surgical management included anterior colporrhaphy with 
or without posterior colporraphy or enterocele repair. Preoperative medical prepara-
tion ordered the use of oral (1 mg estriol/die; T. Ovestin) and local (U. Ovestin; 1 mg/g 
estriol) estrogen for a month. The mean age of the subjects was 59.4 years (8.58 SD, 
median 57 years, ranging from 48 to 72 years), the average number of preceding 
pregnancies was 3.33 (1.68 SD) with 2,46 deliveries (1.46 SD). The pelvic muscle 
function was measured 1 month before (at the beginning of the preoperative prepara-
tion), 1 day before and 1 month after the operation. The following factors were 
measured: pelvic ﬂ oor muscle activity, ability to relax and differences between left and 
right sides. The measurement of muscle parameters was performed by intravaginal 
surface EMG equipment. The statistical data were calculated according to mean, 
standard deviation, median, range, Fisher’s exact test, Student’s t-test methods and 
the results were considered to be signiﬁ cant at P < 0.05. RESULTS: In the preoperative 
period (from the 1st to the 2nd measurement) a signiﬁ cant recovery (p = 0.03) was 
found in the ability to relax pelvic ﬂ oor muscle. In comparison of the 2nd and the 3rd 
measurement a signiﬁ cant decrease occurred in the average muscle activity (p = 0.054) 
and on the left (p = 0.034) side. The difference in the results of the 1st and the 3rd 
measurement was even more signiﬁ cant (p = 0.005), there was a 20.8% average muscle 
activity decrease during this period. CONCLUSIONS: The results suggest to follow 
up the function of pelvic ﬂ oor muscles in the perioperative period of colporrhaphy, 
and if it is necessary to begin the proper physiotherapeutic treatment. 
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PIH9
COST COMPARISON OF MIDWIFE-LED VERSUS OTHER MODELS OF 
CARE FOR CHILDBEARING WOMEN FROM THE PRIVATE PAYER 
PERSPECTIVE IN BRAZIL
Takemoto ML, Fernandes RA, Passos RB, Cukier FN, Tolentino ACM
ANOVA—Knowledge Translation, Rio de Janeiro, Rio de Janeiro, Brazil
OBJECTIVES: Efﬁ cacy of midwife-led models of care (MLMC) has been already 
assessed in a Cochrane systematic review (Hatem 2008) but there is a lack of cost 
comparisons in Brazil. This study aims to compare costs and consequences of MLMC 
versus other models of care (OMC) for women with low or mixed risk of complica-
tions from the private payer perspective. METHODS: Efﬁ cacy data was obtained from 
Hatem 2008 which compared MLMC with OMC including models centered in obste-
tricians, family doctors or shared models. As major maternal and neonatal events had 
not shown statistically signiﬁ cant differences between groups, efﬁ cacy of both models 
was considered similar. Signiﬁ cant differences in favor of MLMC (analgesia, episi-
otomy, instrumental birth, etc.) were used only for cost estimation. Resource use was 
obtained through local published data and input from clinical experts. Only direct 
medical costs related to the delivery room setting were considered. Unit costs were 
obtained from Brazilian ofﬁ cial sources. RESULTS: Risk Ratios for regional analgesia 
(RR = 0.81) and episiotomy (RR = 0.82) were selected as important for the adopted 
setting. The current episiotomy rates in Brazil varied from 76.20% to 94.50% due to 
differences between studies and regional analgesia rate was 99.40% in the only identi-
ﬁ ed study. The incremental estimated costs for one additional episiotomy and analge-
sia were 42.82 BRL and 359.95 BRL, respectively. For each 1000 deliveries in the 
private setting, 137 to 170 episiotomies and 179 analgesias would be prevented with 
the adoption of MLMC, resulting in cost savings of 70,274 to 71,685 BRL. CONCLU-
SIONS: MLMC has shown similar efﬁ cacy and safety proﬁ les when compared with 
OMC and our ﬁ ndings indicated potential cost savings with MLMC in the Brazilian 
private system. Further researches including other clinical outcomes, longer follow-up 
and complications as results of medical interventions could result in higher savings 
for the private payer.
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TREATMENT AND COST FOR PATIENTS WITH ENDOMETRIOSIS IN 
THE UNITED KINGDOM
Wasiak R1, Manson S1, Ryan J2, Petri JC3
1United BioSource Corporation, London, UK; 2Bayer Schering Pharma AG, Newbury, UK; 
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OBJECTIVES: Endometriosis is deﬁ ned by the growth of endometrial tissue outside 
the uterine cavity. It is a common and debilitating benign gynecological condition 
affecting mainly reproductive-age women with prevalence estimated between 
7%–10% of women. The purpose of this study was to understand the cost associated 
with endometriosis in a secondary care setting in the UK. METHODS: A retrospective 
analysis was performed using secondary care data from the Cardiff and Vale National 
Health Service Hospitals Trust including 411 patients diagnosed with endometriosis. 
a supplementary postal survey was completed by a subset of 80 patients. Data included 
information on hospital stays, surgical procedures, prescriptions, as well as survey 
data on primary care treatment, quality of life and productivity loss. Patients were 
classiﬁ ed into surgical or clinical diagnosis groups depending on type of diagnosis: 
laparoscopy/laparotomy, or clinician’s assessment only. RESULTS: For hospital visits 
with endometriosis as primary diagnosis, patients with a surgical diagnosis (n = 89) 
experienced an average hospital stay duration of 0.4 days (SD = 0.7) compared to 2.2 
days (SD = 3.4) for patients with a clinical diagnosis (n = 322). The average cost per 
hospital visit was £871 (surgical group) and £1525 (clinical group). Patients with 
clinical diagnosis also had more GP visits in the 6 weeks prior to their hospital visit 
(mean 2.0 (SD = 2.9) vs. 1.4 (SD = 1.4)). The most common endometriosis-speciﬁ c 
pharmacotherapy used in a secondary setting was GnRH agonists (22%) followed by 
progestins (11%) and oral contraceptives (10%) with drug use in the surgical group 
exceeding that of the clinical group. Patient utility as measured by the EQ-5D was 
similar for surgically and clinically diagnosed patients (0.70, SD = 0.32 vs. 0.71, SD 
= 0.27). CONCLUSIONS: This study demonstrates that there are substantial costs 
involved in treating patients in a secondary care setting, with a different pattern of 
endometriosis-related costs for patients without a conﬁ rmed diagnosis of 
endometriosis.
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SOCIETAL IMPACT OF DIARRHEA IN YOUNG CHILDREN IN THE 
NETHERLANDS
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OBJECTIVES: Diarrhoea is one of the most common childhood diseases. This study 
examined the medical resources use and societal impact related to diarrhoea in young 
children in the The Netherlands. METHODS: In 2007 an Internet survey question-
naire on childhood diseases was administered to a representative sample of parents 
with children aged <5 years. The survey covered socio-demographic data, character-
istics of the most recent disease episode, medical resources use, productivity loss by 
the caregivers, and travel-related costs. Data were available for 2425 respondents. 
This study focused on diarrhoea episodes. Diarrhoea was deﬁ ned as symptoms and/
or diagnosis of diarrhoea only or diarrhoea in combination with symptoms of fever 
and/or vomiting; i.e. diarrhoea without concomitant diseases. RESULTS: In total 128 
episodes of diarrhoea were reported. In 27% of these episodes a general practitioner 
had been consulted, in 2% a paediatrician, and in 4% an emergency department had 
been visited. In 59% of the diarrhoea episodes no medical doctor was consulted. 
Hospital admission occurred in 3% of the cases (mean duration 2 days). Over-the-
counter drugs were bought in 41% of the episodes. In 17% of the diarrhoea episodes 
caregivers lost days from a paid job (mean 16.4 hours per episode; SD 15.8). In 19% 
of the episodes parents reported productivity loss at work during their child’s illness 
(mean 6.3 hours per episode; SD 5.9). Leisure time loss was reported in 29% of the 
episodes (mean 2.3 hours per episode; SD 2.5). The mean costs were estimated to be 
c208,- per diarrhoea episode, of which 23.3% direct medical costs, 10.3% direct 
non-medical, and 66.4% indirect non-medical costs. CONCLUSIONS: The medical 
and economic burden of diarrhoea is considerable to individual families as well as to 
society in the The Netherlands. This study has ﬁ lled a gap in the knowledge base on 
the impact of diarrhoea on society.
